Skip to main content

Ferumoxytol Side Effects

Medically reviewed by Drugs.com. Last updated on Dec 3, 2023.

Applies to ferumoxytol: intravenous solution.

Warning

Intravenous route (Solution)

Risk For Serious Hypersensitivity/Anaphylaxis ReactionsFatal and serious hypersensitivity reactions, including anaphylaxis, have occurred in patients receiving ferumoxytol. Initial symptoms may include hypotension, syncope, unresponsiveness, and cardiac or cardiorespiratory arrest.Only administer ferumoxytol as an intravenous infusion over at least 15 minutes and only when personnel and therapies are immediately available for the treatment of anaphylaxis and other hypersensitivity reactions.Observe for signs or symptoms of hypersensitivity reactions during and for at least 30 minutes following ferumoxytol infusion including monitoring of blood pressure and pulse during and after ferumoxytol administration.Hypersensitivity reactions have occurred in patients in whom a previous ferumoxytol dose was tolerated.

Serious side effects of Ferumoxytol

Along with its needed effects, ferumoxytol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking ferumoxytol:

Less common

Incidence not known

Other side effects of Ferumoxytol

Some side effects of ferumoxytol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

For Healthcare Professionals

Applies to ferumoxytol: intravenous solution.

General

The most common adverse events were injection site reactions, gastrointestinal symptoms, headache, dizziness, and hypotension.[Ref]

Local

Common (1% to 10%): Injection site reactions (infusion/injection site bruising, pain, reaction, swelling, warmth, hemorrhage, irritation, rash)[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, vomiting, abdominal pain (abdominal distension, abdominal pain upper, abdominal discomfort)

Uncommon (0.1% to 1%): Diarrhea, constipation, feces discolored

Rare (less than 0.1%): Dry mouth, dyspepsia, glossodynia

Frequency not reported: Lip swelling, swollen tongue[Ref]

Cardiovascular

Common (1% to 10%): Hypotension (hypotension, blood pressure decreased)

Uncommon (0.1% to 1%): Flushing (flushing, hot flush), hypertension (hypertension, accelerated hypertension)

Rare (less than 0.1%): Cardiac arrest, cardio-respiratory arrest, myocardial events, congestive heart failure

Frequency not reported: Tachycardia/arrhythmia, myocardial infarction, vasodilation, pulse absent

Postmarketing reports: Cyanosis[Ref]

Nervous system

Common (1% to 10%): Dizziness, headache

Uncommon (0.1% to 1%): Dysgeusia, somnolence, burning sensation

Rare (less than 0.1%): Paresthesia

Frequency not reported: Syncope, unresponsiveness, loss of consciousness[Ref]

Dermatologic

Common (1% to 10%): Pruritus (pruritus generalized), rash (rash, rash generalized, rash pruritic, urticaria)

Uncommon (0.1% to 1%): Ecchymosis, sweating (hyperhidrosis, night sweats), skin hyperpigmentation, skin reaction

Frequency not reported: Angioedema[Ref]

Respiratory

Common (1% to 10%): Cough, dyspnea

Rare (less than 0.1%): Epistaxis

Frequency not reported: Bronchospasm, hyperventilation, hypoxia, laryngeal edema, pharyngeal edema, respiratory arrest, respiratory failure, throat irritation, throat tightness, wheezing[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, muscle spasms

Uncommon (0.1% to 1%): Muscle/joint pain or stiffness (arthralgia, myalgia, muscular weakness, musculoskeletal stiffness)[Ref]

Metabolic

Common (1% to 10%): Edema

Uncommon (0.1% to 1%): Decreased appetite, increased appetite

Rare (less than 0.1%): Dehydration, gout, hyperkalemia, blood glucose decreased

Frequency not reported: Oxygen saturation decreased[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity (including anaphylaxis)

Postmarketing reports: Life-threatening anaphylactic/anaphylactoid reactions[Ref]

Hematologic

Rare (less than 0.1%): Eosinophilia[Ref]

Hepatic

Rare (less than 0.1%): Hepatic function abnormal[Ref]

Other

Common (1% to 10%): Peripheral edema, chest pain (chest discomfort, chest pain), fever (feeling hot, pyrexia)

Uncommon (0.1% to 1%): Fatigue (asthenia, fatigue), chills, serum ferritin increased, contusion[Ref]

Ocular

Rare (less than 0.1%): Lacrimation increased, vision blurred[Ref]

Renal

Frequency not reported: Chronic renal failure[Ref]

References

1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Product Information. Feraheme (ferumoxytol). Alza Pharmaceuticals. 2009.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.